Xiao-Ke-Shen-An formula alleviates inflammation, oxidative stress and fibrosis in diabetic kidney disease via JAK2/STAT3 and metabolic regulation
Traditional Medicine Research · 2027 · 12 (1) · 3
DOI: 10.53388/tmr2027003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Traditional Medicine Research, 2027. Verfasst von He-Ying Cui und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Background
The Xiao-Ke-Shen-An (XKSA) formula, as a traditional Chinese medicine for treating diabetic kidney disease (DKD), has demonstrated clinical benefits in alleviating diabetic complications and protecting renal function. However, the mechanism of action remains unclear. This study integrates network pharmacology, molecular docking, and metabolomics techniques to explore the potential mechanism of XKSA formula in treating DKD.
Methods
UHPLC-MS/MS was used to identify the components of XKSA. Network pharmacology was applied to predict key signaling pathways, followed by metabolomics to identify differential metabolites. HE, PAS, and Masson staining were used to detect pathological damage of glomeruli and renal tubules; transmission electron microscopy was used to observe mitochondrial structure; ELISA, Western blotting, and immunofluorescence staining were used to verify the mechanism of XKSA in treating DKD.
Results
26 main active components were identified by UHPLC-MS/MS analysis; network pharmacology analysis indicated that the JAK2/STAT3 pathway was a key regulatory pathway; metabolomics analysis showed that the XKSA formula significantly regulated 7 metabolites, including indoxyl sulfate (IS). In vivo experiments showed that the XKSA formula could significantly improve glycolipid metabolism disorders, enhance renal function, and alleviate renal pathological damage; in vivo and in vitro experiments found that XKSA reduced the expression of inflammatory factors, enhanced antioxidant capacity, improved mitochondrial structure, inhibited the expression of fibrotic proteins, and inhibited the activation of the JAK2/STAT3 pathway. In addition, IS stimulation could up-regulate KIM-1 protein expression, while XKSA down-regulated this expression in a dose-dependent manner and inhibited inflammation and oxidative stress, reversing the fibrotic trend.
Conclusion
XKSA reduces the IS level and inhibits the JAK2/STAT3 signaling pathway, thereby alleviating the renal inflammation, oxidative stress and fibrosis caused by DKD.
Zitieren
APA
Cui, H., Xu, P., Li, X., Zheng, S., Lin, C., Piao, M., & Nan, Z. (2027). Xiao-Ke-Shen-An formula alleviates inflammation, oxidative stress and fibrosis in diabetic kidney disease via JAK2/STAT3 and metabolic regulation. Traditional Medicine Research, 12(1), 3. https://doi.org/10.53388/tmr2027003
Vancouver
Cui H, Xu P, Li X, Zheng S, Lin C, Piao M, et al. Xiao-Ke-Shen-An formula alleviates inflammation, oxidative stress and fibrosis in diabetic kidney disease via JAK2/STAT3 and metabolic regulation. Traditional Medicine Research. 2027;12(1):3. doi:10.53388/tmr2027003
BibTeX
@article{Cui2027,
author = {Cui, He-Ying and Xu, Peng-Bin and Li, Xiang-Dan and Zheng, Shu-Hua and Lin, Chang-Qing and Piao, Min-Hu and Nan, Zheng},
title = {Xiao-Ke-Shen-An formula alleviates inflammation, oxidative stress and fibrosis in diabetic kidney disease via JAK2/STAT3 and metabolic regulation},
journal = {Traditional Medicine Research},
year = {2027},
volume = {12},
number = {1},
pages = {3},
doi = {10.53388/tmr2027003}
}
EUVIMED